Clinical and Atherosclerotic Characteristics of Patients With ACS Associated With Cocaine Use
Launched by HOSPITAL EL CRUCE · Dec 10, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the health effects of cocaine use on patients who have experienced Acute Coronary Syndrome (ACS), which is a term that describes a range of conditions related to sudden reduced blood flow to the heart, often leading to a heart attack. The researchers want to learn more about how cocaine use influences the severity of heart disease and to compare these patients with those who have ACS but do not use cocaine. This is important because there is limited information on this topic in Argentina, where cocaine use has been rising.
To participate in the study, you need to be at least 18 years old and have been hospitalized for ACS as confirmed by your doctor. If you decide to join, you'll be asked to share information about your health and cocaine use. The study will involve collecting data from patients in a hospital and will not interfere with your regular treatment. Your participation will help researchers better understand the connection between cocaine use and heart disease, which could improve care for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥18
- • Hospitalization due to diagnosis of ACS, made by the treating medical team.
- For the prospective stage, it will be added:
- • Acceptance to participate in the study and willingness to sign the informed consent.
- Exclusion Criteria:
- • Patients who, due to their clinical condition, cannot be interviewed to determine their history of cocaine use.
About Hospital El Cruce
Hospital El Cruce is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Located in Buenos Aires, Argentina, the hospital is renowned for its multidisciplinary approach, combining cutting-edge technology with a commitment to evidence-based practices. As a clinical trial sponsor, Hospital El Cruce prioritizes patient safety and ethical standards while fostering collaboration with researchers and healthcare professionals. The institution aims to contribute valuable insights to the medical community by exploring new therapies and treatment modalities across various fields, ultimately enhancing the quality of care for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Florencio Varela, Buenos Aires, Argentina
Patients applied
Trial Officials
Maximiliano de Abreu, PhD
Principal Investigator
Hospital El Cruce
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported